Heartflow, Inc. (HTFL)
Healthcare • Health Information Services
StockNasdaqGSUnited StatesUS42238D1072
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Heartflow, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 10:19. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 12 Nov 2026 16:00 | -0.10 | -0.03 | +70.7% | Beat |
| 13 Aug 2026 16:00 | -0.13 | — | — | — |
| 14 May 2026 16:00 | -0.17 | -0.16 | +8.5% | Beat |
| 18 Mar 2026 16:00 | -0.16 | -0.12 | +23.2% | Beat |
| 12 Nov 2025 16:00 | -0.24 | -0.27 | -12.5% | Miss |
| 19 Sep 2025 08:00 | -0.21 | -1.10 | -417.4% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 176M | +39.9% | -116.8M | -66.3% | -3.17 | -165.0% | -59M |
| 2024 | 125.8M | +44.3% | -96.4M | -76.6% | -1.20 | +38.2% | -73.4M |
| 2023 | 87.2M | — | -95.7M | -109.7% | -1.94 | — | -82.5M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 59.14 | 60.65 | 51.06 | 59.92 | +1.47% | 17,134,300 | |
| Oct 2026 | 49.81 | 60.56 | 46.50 | 59.05 | +18.69% | 36,671,900 | |
| Sep 2026 | 50.28 | 52.22 | 45.41 | 49.75 | -1.27% | 41,334,300 | |
| Aug 2026 | 25.92 | 51.19 | 25.38 | 50.39 | +99.72% | 44,875,900 | |
| Jul 2026 | 29.35 | 30.98 | 23.87 | 25.23 | -14.01% | 26,976,400 | |
| Jun 2026 | 30.93 | 36.46 | 27.68 | 29.34 | -5.29% | 42,902,800 | |
| May 2026 | 29.61 | 32.60 | 24.77 | 30.98 | +4.10% | 23,227,200 | |
| Apr 2026 | 24.67 | 33.38 | 23.19 | 29.76 | +22.32% | 24,872,300 | |
| Mar 2026 | 22.53 | 28.98 | 20.41 | 24.33 | +5.05% | 34,954,100 | |
| Feb 2026 | 29.59 | 30.19 | 20.13 | 23.16 | -22.46% | 40,887,500 | |
| 6 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- What Heartflow (HTFL) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 13 Nov 2026 03:14
- HeartFlow (HTFL) Reports Q3 Loss, Beats Revenue Estimates (opens in a new tab) Zacks · 12 Nov 2026 21:25
- HeartFlow: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 12 Nov 2026 21:19
- Heartflow Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance (opens in a new tab) 12 Nov 2026 21:01
- HeartFlow (HTFL) Stock May Be Overvalued On Fresh Plaque Analysis Data (opens in a new tab) Simply Wall St. · 03 Nov 2026 09:11
- HeartFlow (HTFL) Shares Moved, What Is Behind The Attention? (opens in a new tab) Simply Wall St. · 03 Nov 2026 06:11
- AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry (opens in a new tab) 02 Nov 2026 13:00
- Heartflow To Present DECIDE Registry Data Showing 34% Reduction In Major Cardiovascular Events With AI Plaque Analysis, At AHA Scientific Sessions 2026 (opens in a new tab) Benzinga · 02 Nov 2026 09:03
- TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients (opens in a new tab) 01 Nov 2026 18:45
- Boston Scientific (BSX) Wins FDA Clearances, Starts Elite AF Trial And Expands AI Push (opens in a new tab) Simply Wall St. · 29 Oct 2026 19:15
- AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion (opens in a new tab) Insider Monkey · 29 Sep 2026 16:24
- BCSM Exits Heartflow (HTFL) on Competitive Concerns (opens in a new tab) Insider Monkey · 17 Sep 2026 13:49
- HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High (opens in a new tab) Motley Fool · 15 Sep 2026 20:56
- HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High (opens in a new tab) Motley Fool · 06 Sep 2026 07:11
- HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors? (opens in a new tab) Motley Fool · 20 Aug 2026 17:00
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 59.10 USD
- Market cap
- 5.2B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Health Information Services
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 25.0 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 3.9 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 0.0 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 0.0 / 10 |
|
- Score capped at 60: free cash flow was negative in two of the last three years
- Thin interest cover: operating profit is only -4.2× the interest
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 12 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | -221.25× | Weak | 14.16× |
| Price / book | 18.57× | Weak | 3.5× |
| Price / sales | 24.57× | Weak | 3.33× |
| EV / EBITDA | -71.12× | Weak | 11.19× |
| Free cash flow yield | -0.6% | Weak | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 80.1% | Good | 54.9% |
| Operating margin | -34.3% | Weak | 5.8% |
| Net margin | -55.8% | Weak | 1.2% |
| Return on equity | -154.2% | Weak | 4.4% |
| Return on assets | -18.1% | Weak | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 42.1% | Good | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.1× | Good | 0.4× |
| Interest cover | -4.22× | Weak | 2.17× |
| Current ratio | 5.08× | Good | 2.64× |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow HTFL and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.